Search research articles
Contact Us
Filters
Showing results (161-170 of 176) with videos related to
Page
of 18
Sort By:
Clinical Genitourinary Cancer
|
December 3, 2014
A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer
Kevin D Courtney, Judith B Manola, Aymen A Elfiky, et al.
Antiviral Research
|
March 12, 2022
A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors
K Y Chen, T Krischuns, L Ortega Varga, et al.
Cell Metabolism
|
August 28, 2018
Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo
Kevin D Courtney, Divya Bezwada, Tomoyuki Mashimo, et al.
Advances in Radiation Oncology
|
September 22, 2025
Extracranial Palliative Radiation Therapy for Renal Cell Carcinoma
Young Suk Kwon, Eric Hsu, Maggie Stein, et al.
Nature Chemical Biology
|
October 25, 2019
Author Correction: MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG
Louise Fets, Paul C Driscoll, Fiona Grimm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2025
COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts
Sumanta K Pal, Yohann Loriot, Andrea Necchi, et al.
American Journal of Human Genetics
|
August 6, 2013
Short-rib polydactyly and Jeune syndromes are caused by mutations in WDR60
Aideen M McInerney-Leo, Miriam Schmidts, Claudio R Cortés, et al.
Nature Chemical Biology
|
October 10, 2018
MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG
Louise Fets, Paul C Driscoll, Fiona Grimm, et al.
Nature
|
July 4, 2014
Attenuated sensing of SHH by Ptch1 underlies evolution of bovine limbs
Javier Lopez-Rios, Amandine Duchesne, Dario Speziale, et al.
Frontiers in Oncology
|
January 22, 2025
Initial clinical experience with [<sup>177</sup>Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial
Aaron R Hansen, Stephan Probst, Jean-Mathieu Beauregard, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 176) with videos related to
Sort By:
Page
of 18
Clinical Genitourinary Cancer
|
December 3, 2014
A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer
Kevin D Courtney, Judith B Manola, Aymen A Elfiky, et al.
Antiviral Research
|
March 12, 2022
A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors
K Y Chen, T Krischuns, L Ortega Varga, et al.
Cell Metabolism
|
August 28, 2018
Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo
Kevin D Courtney, Divya Bezwada, Tomoyuki Mashimo, et al.
Advances in Radiation Oncology
|
September 22, 2025
Extracranial Palliative Radiation Therapy for Renal Cell Carcinoma
Young Suk Kwon, Eric Hsu, Maggie Stein, et al.
Nature Chemical Biology
|
October 25, 2019
Author Correction: MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG
Louise Fets, Paul C Driscoll, Fiona Grimm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2025
COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts
Sumanta K Pal, Yohann Loriot, Andrea Necchi, et al.
American Journal of Human Genetics
|
August 6, 2013
Short-rib polydactyly and Jeune syndromes are caused by mutations in WDR60
Aideen M McInerney-Leo, Miriam Schmidts, Claudio R Cortés, et al.
Nature Chemical Biology
|
October 10, 2018
MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG
Louise Fets, Paul C Driscoll, Fiona Grimm, et al.
Nature
|
July 4, 2014
Attenuated sensing of SHH by Ptch1 underlies evolution of bovine limbs
Javier Lopez-Rios, Amandine Duchesne, Dario Speziale, et al.
Frontiers in Oncology
|
January 22, 2025
Initial clinical experience with [<sup>177</sup>Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial
Aaron R Hansen, Stephan Probst, Jean-Mathieu Beauregard, et al.
Page
of 18